5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression-Reference-Cited by-同舟云学术

5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression

Published:2017-05-02 Issue:28 Volume:8 Page:46163-46176
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Morel Adrien¹,Baguet Aurélie¹,Perrard Jérôme¹,Demeret Caroline²,Jacquin Elise³,Guenat David⁴⁵,Mougin Christiane¹⁴,Prétet Jean-Luc¹⁴

Affiliation:

1. EA3181, Université Bourgogne Franche-Comté, LabEx LipSTIC ANR-11-LABX-0021, Besançon, France

2. Département de Virologie, Institut Pasteur, Unité de Génétique Moléculaire des Virus à ARN, CNRS UMR 3569, Université Paris Diderot, Sorbonne Paris Cité, Paris, France

3. Signalling Department, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom

4. Centre Hospitalier Régional Universitaire, Besançon, France

5. Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University, Stanford, California, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of Systemic Therapies in Penile Cancer;Urologic Clinics of North America;2024-08

2. Insights into the management of penile squamous cell carcinoma: from conventional approaches to emerging novel therapies;Expert Opinion on Pharmacotherapy;2024-03-03

3. Epigenetic orchestration of the DNA damage response: Insights into the regulatory mechanisms;International Review of Cell and Molecular Biology;2024

4. Diverse roles of miRNAs in breast cancer and gynecologic cancers;MicroRNA in Human Infectious Diseases;2024

5. Epigenetic and Genetic Keys to Fight HPV-Related Cancers;Cancers;2023-11-25